European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading

European equities traded in the US as American depositary receipts were heading lower late Friday morning, declining 0.49% to 1,445.71 on the S&P Europe Select ADR Index. Despite the decline, the index is still poised to end the week up about 1.3%.

From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and semiconductor company Sequans Communications (SQNS), which rose 6% and 4.6% respectively. They were followed by medical device maker EDAP (EDAP) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which were up 1% and 0.6% respectively.

The decliners from continental Europe were led by biopharmaceutical companies DBV Technologies (DBVT) and Calliditas Therapeutics (CALT), which fell 10% and 4.6% respectively. They were followed by biopharmaceutical companies Cellectis (CLLS) and Grifols (GRFS), which dropped 3.4% and 2.9% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP), which rose 1.5%. It was followed by software firm Endava (DAVA) and biopharmaceutical company Mereo BioPharma Group (MREO), which were up 0.9% and 0.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm (TCBP) and NuCana (NCNA), which lost 7.8% and 4.7% respectively. They were followed by insurance firm Prudential (PUK) and mining company BHP Group (BHP), which were down 3.4% and 1.6% respectively.